10(S),17(S)-DiHDHA
10(S),17(S)-DiHDHA (also known as neuroprotectin D1 when produced in neuronal tissues) is a DHA-derived dihydroxy fatty acid that exhibits potent protective and anti-inflammatory activities.
For research use only. We do not sell to patients.
- CAS No.: 871826-47-0
- Formula: C22H32O4
- Molecular Weight:360.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-116124
17(S)-HpDHAHydrolyzate -
HY-113533
Resolvin D4Proresolving Mediator -
HY-130413
Protectin D1Neuroprotectin D1 -
HY-116429
Maresin 1Ca2+ Stimulator -
HY-129466
PCTR2Pro-resolving Mediator -
HY-119684
Maresin 2Anti-inflammatory And Pro-resolving Mediator -
HY-145474
17(R)-Resolvin D1 methyl esterAnti-inflammatory Agent -
HY-125408
Maresin conjugates in tissue regeneration 1cytokine -
HY-130322
Maresin Conjugates in Tissue Regeneration 2Specialized Pro-resolving Mediator -
HY-145543
9(S)10(S)13(S)-TriHOMEEster Product -
HY-W708469
Resolvin D2 methyl ester -
HY-120312
PCTR3Pro-Resolving Mediator
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
Chemical Information
-
CAS No. 871826-47-0
-
Appearance Solid
-
Molecular Weight 360.49
-
Formula C22H32O4
-
Color White to off-white
-
SMILES
CC/C=C\C[C@H](O)/C=C/C=C\C=C\[C@@H](O)C/C=C\C/C=C\CCC(O)=O
-
Synonyms
10(S),17(S)-DiHDoHE; PDX
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
-
Data Sheet (261 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol. 2006 Feb 1;176(3):1848-59. [Content Brief]
[2]. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007 Jun 14;447(7146):869-74. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
10(S),17(S)-DiHDHA Related Classifications
HY-130285 Related Classifications
Powered by Bioz